UiPath, Inc. (PATH) CEO discloses Rule 10b5-1 stock sales on Form 4

Rhea-AI Filing Summary

UiPath, Inc.'s CEO, Chairman, director and 10% owner filed a report disclosing sales of Class A common stock. On 12/12/2025, the reporting person sold 45,000 shares at $17.9061, leaving 29,018,585 shares beneficially owned directly. On 12/15/2025, they sold another 45,000 shares at $17.2986, leaving 28,973,585 shares beneficially owned directly.

The shares were sold in compliance with a qualified selling plan adopted under Rule 10b5-1. The filing notes price ranges of $17.7300 to $18.0700 for the first set of transactions and $17.0100 to $17.5900 for the second. No derivative securities transactions were reported in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dines Daniel

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Commmon Stock	12/12/2025		S		45,000(1)	D	$17.9061(2)	29,018,585	D
Class A Commmon Stock	12/15/2025		S		45,000(1)	D	$17.2986(3)	28,973,585	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $17.7300 to $18.0700. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

3. The range of prices for the transactions reported was from $17.0100 to $17.5900. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did UiPath (PATH) disclose in this Form 4?

The filing reports that UiPath's CEO, Chairman, director and 10% owner sold 45,000 shares of Class A common stock on 12/12/2025 at $17.9061 and another 45,000 shares on 12/15/2025 at $17.2986.

How many UiPath (PATH) shares does the reporting person own after the reported sales?

After the 12/12/2025 sale, the reporting person beneficially owned 29,018,585 shares of Class A common stock directly. After the 12/15/2025 sale, direct beneficial ownership was 28,973,585 shares.

Were the UiPath (PATH) share sales made under a Rule 10b5-1 trading plan?

Yes. The filing states that the 45,000-share sales were made in compliance with a qualified selling plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.

What price ranges were reported for the UiPath (PATH) stock sales?

For the 12/12/2025 transactions, the price range was from $17.7300 to $18.0700. For the 12/15/2025 transactions, the range was from $17.0100 to $17.5900.

Did this UiPath (PATH) Form 4 report any derivative securities transactions?

No. The section for derivative securities such as options or warrants did not list any acquired, disposed, or beneficially owned derivative securities.

Is the Form 4 filed for more than one reporting person at UiPath (PATH)?

No. The filing indicates that it is a Form filed by one reporting person, not a joint or group filing.